Patent · US Active

Compounds and methods for treating autoimmune diseases

US8741905B2 · kind B2 · utility

3Cited by
0References
34Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 6, 2013
Grant dateJun 3, 2014
Priority date
Expiry dateMay 6, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a compound of Formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.